Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1960 1
1965 1
1966 1
1967 1
1969 1
1970 2
1971 1
1972 4
1973 2
1974 1
1976 2
1977 4
1978 3
1979 1
1980 6
1981 4
1982 3
1983 2
1984 2
1985 6
1986 5
1987 6
1988 5
1989 7
1990 9
1991 3
1992 8
1993 8
1994 7
1995 5
1996 5
1997 6
1998 1
1999 1
2000 1
2001 2
2002 4
2003 4
2004 8
2005 3
2006 7
2007 12
2008 4
2009 4
2010 6
2011 3
2012 6
2013 4
2014 2
2015 1
2016 4
2017 2
2018 2
2019 1
2020 3
2021 7
2022 7
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Results by year

Filters applied: . Clear all
Page 1
Atogepant for the Preventive Treatment of Migraine.
Ailani J, Lipton RB, Goadsby PJ, Guo H, Miceli R, Severt L, Finnegan M, Trugman JM; ADVANCE Study Group. Ailani J, et al. N Engl J Med. 2021 Aug 19;385(8):695-706. doi: 10.1056/NEJMoa2035908. N Engl J Med. 2021. PMID: 34407343 Clinical Trial.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Retinal remodeling in human retinitis pigmentosa.
Jones BW, Pfeiffer RL, Ferrell WD, Watt CB, Marmor M, Marc RE. Jones BW, et al. Among authors: ferrell wd. Exp Eye Res. 2016 Sep;150:149-65. doi: 10.1016/j.exer.2016.03.018. Epub 2016 Mar 26. Exp Eye Res. 2016. PMID: 27020758 Free PMC article. Review.
Rheumatic Disease: Protease-Activated Receptor-2 in Synovial Joint Pathobiology.
McCulloch K, McGrath S, Huesa C, Dunning L, Litherland G, Crilly A, Hultin L, Ferrell WR, Lockhart JC, Goodyear CS. McCulloch K, et al. Among authors: ferrell wr. Front Endocrinol (Lausanne). 2018 May 23;9:257. doi: 10.3389/fendo.2018.00257. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29875735 Free PMC article. Review.
Delayed force feedback.
Ferrell WR. Ferrell WR. Hum Factors. 1966 Oct;8(5):449-55. doi: 10.1177/001872086600800509. Hum Factors. 1966. PMID: 5966936 No abstract available.
Acute joint inflammation--mechanisms and mediators.
Scott DT, Lam FY, Ferrell WR. Scott DT, et al. Among authors: ferrell wr. Gen Pharmacol. 1994 Nov;25(7):1285-96. doi: 10.1016/0306-3623(94)90151-1. Gen Pharmacol. 1994. PMID: 7896038 Review.
Immunomodulatory role of proteinase-activated receptor-2.
Crilly A, Palmer H, Nickdel MB, Dunning L, Lockhart JC, Plevin R, McInnes IB, Ferrell WR. Crilly A, et al. Among authors: ferrell wr. Ann Rheum Dis. 2012 Sep;71(9):1559-66. doi: 10.1136/annrheumdis-2011-200869. Epub 2012 May 6. Ann Rheum Dis. 2012. PMID: 22563031 Free PMC article.
213 results